Implementing the Nurse-led Optimization of Volume and blood pressure - Enabling at multi-Levels using TechnologY (NOVELTY) program for Chronic Kidney Disease: a prospective cohort study [0.03%]
用于慢性肾脏病的以护士为主导的血容量和血压多级技术赋能优化计划（NOVELTY）的效果：前瞻性队列研究
Zhihua Huang,Li Choo Ng,Irene Mok et al.
Zhihua Huang et al.
Background: Fluid overload is a common manifestation of chronic kidney disease (CKD) and is associated with increased hospitalizations and death. However, severe symptomatic fluid overload is potentially preventable with ...
Acute Tubular Necrosis Attributed to High-Dose Everolimus with High-Potency Bisphosphonates for Advanced Breast Cancer - A Case Report [0.03%]
高剂量依维莫司联合高强度双膦酸盐治疗晚期乳腺癌致急性肾小管坏死1例报告
Itamar Loewenstein,Nimrod Orr Urtreger,Doron Schwartz et al.
Itamar Loewenstein et al.
Introduction: Everolimus (EVR)-induced kidney injury is rarely reported. Conversely, acute tubular necrosis (ATN) is a recognized complication of high-dose bisphosphonate therapy. ...
Case Reports
Nephron. 2025 Feb 3:1-11. DOI:10.1159/000543924 2025
Understanding the Support Needs of People with Autosomal Dominant Polycystic Kidney Disease: A Qualitative Phenomenological Descriptive Study [0.03%]
对常染色体显性多囊肾病患者支持需求的理解：一种质性现象学描述研究
Katrine Schmidt Rasmussen,Dinah Sherzad Khatir,Henrik Birn et al.
Katrine Schmidt Rasmussen et al.
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is a prevalent hereditary kidney disease and the fourth most common cause of kidney failure. Patients may be aware of their condition from an early age or...
Thomas McDonnell,Rosamonde E Banks,Maarten W Taal et al.
Thomas McDonnell et al.
The ultimate goal of precision medicine is to tailor treatment to specific disease processes, thereby optimising patient outcomes. This approach moves beyond the one-size-fits-all model, recognising at an individual level the unique combina...
Review
Nephron. 2025 Jan 23:1-26. DOI:10.1159/000543640 2025
Prospective Evaluation of Remote Software Based Surveillance Supplementing Clinical Monitoring For Hemodialysis Vascular Access [0.03%]
远程软件补充临床监控进行血液透析血管通路术的前瞻性评估
Alshymaa Rafiek Eltahan,Zulfikar Pondor,Rosemary L Donne et al.
Alshymaa Rafiek Eltahan et al.
Background and hypothesis: Efficient arteriovenous access (VA) surveillance is vital for early identification of dysfunctional access, allowing timely intervention to prevent thrombosis. This study compares the efficacy o...
GlomCon Hawaii: The First International Hybrid Glomerular Diseases Conference [0.03%]
夏威夷国际混合型glomerular疾病会议（GlomCon Hawaii）
Niloufar Ebrahimi,Zohreh Gholizadeh Ghozloujeh,Ali Poyan Mehr et al.
Niloufar Ebrahimi et al.
Luigi Gnudi
Luigi Gnudi
Mendelian Randomization Analysis Reveals a Causal Relationship Between Membranous Nephropathy and the Gut Microbiome [0.03%]
孟德尔随机化分析揭示了膜性肾病与肠道微生物群之间的因果关系
Dunlu Yuan,Yuelong Chen,Hongyun Zheng et al.
Dunlu Yuan et al.
Background: With the increasing prevalence of membranous nephropathy (MN), the gut microbiome (GM) is increasingly implicated in its cause, yet the intricate mechanisms remain unclear. Whether changes in the diversity and...
Recurrence of glomerular diseases after kidney transplantation: What do we know new? [0.03%]
肾移植后复发性glomerular疾病：我们有哪些新认识？
Emilio Rodrigo,Lara Belmar,José Luis Pérez-Canga
Emilio Rodrigo
Background: The recurrence of primary glomerulonephritis (GN) following kidney transplantation poses a significant threat to graft survival. To enhance kidney transplant outcomes, we must lessen the burden of recurrence. ...
Review
Nephron. 2025 Jan 8:1-18. DOI:10.1159/000543268 2025
Metabolic syndrome, non-alcoholic fatty liver disease and graft inflammation: an unaddressed pathogenic link after kidney transplantation [0.03%]
代谢综合征、非酒精性脂肪肝和移植后移植物炎症：一个未被重视的致病联系
Arminda Fariña-Hernández,Ana González-Rinne,Alberto Hernández-Bustabad et al.
Arminda Fariña-Hernández et al.
Kidney transplantation (KT) is the treatment of choice for chronic kidney disease (CKD) patients, but there is a continued loss of grafts in the long-term (50% at 10 years) due to either patient 's death or chronic allograft dysfunction. Me...
Review
Nephron. 2024 Dec 23:1-18. DOI:10.1159/000543276 2024